Search results
Order by most recent / most popular / relevance
Results: 1-10 of 308
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada, USA
- -
- May 22 2013
The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 13 2013
This case involved a dispute over ownership and alleged infringement of copyright in a number of computer software programs. The Court held that the
Teva Canada Innovation v. Attorney General of Canada
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an
Reynolds Presto Products Inc. v. P.R.S. Mediterranean Ltd., 2013 FCA 119
- Borden Ladner Gervais LLP
- -
- Canada
- -
- May 8 2013
The Court of Appeal has overturned a lower court decision and struck the mark NEOWEB from the register because it is confusing with the earlier
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 8 2013
The governments of a number of provinces sought judicial review of a decision of the Copyright Board of Canada dismissing their objection that the
Intellectual property weekly abstracts bulletin
- Borden Ladner Gervais LLP
- -
- Canada
- -
- April 1 2013
The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the
Other cases of interest
- Borden Ladner Gervais LLP
- -
- Canada
- -
- March 25 2013
As mentioned last week, two IP leave decisions were released last Thursday. Neither appeal obtained leave. The first, Gilead Science Canada Inc. v
NOC proceedings
- Borden Ladner Gervais LLP
- -
- Canada
- -
- March 25 2013
The Federal Court found Teva’s allegations of invalidity were not justified for Novartis’ narrow compound patent, while the allegations against
Decisions in leave to appeal to the Supreme Court
- Borden Ladner Gervais LLP
- -
- Canada
- -
- March 18 2013
The Supreme Court is releasing their judgment for two leave decisions this Thursday. The first, Gilead Science Canada Inc. v. Minister of Health
Liability for section 8 damages upheld
- Borden Ladner Gervais LLP
- -
- Canada
- -
- March 18 2013
AstraZeneca appealed the decision of the Trial Judge with respect to liability for damages pursuant to s. 8 of the NOC Regulations (decision here, our
Current Search
- Jurisdiction - Canada
- Author - Chantal Saunders
- Workarea - Litigation
Suggested Facets
Author
- Adrian Howard (16)
- Anne Kinsman (1)
- Beverley Moore (306)
- Mandy Moore (1)
- Mukundan Chakrapani, Ph.D (1)
- Steven Kennedy (1)